LDH2

Toxoplasma gondii LDH2 is a bradyzoite-specific lactate dehydrogenase that supports the parasite's metabolic and developmental transition to the chronic cyst stage (PMID:9016946, PMID:29028143). It arose as a homolog of the constitutive tachyzoite enzyme LDH1 (71.1% identity), but its mRNA and cytoplasmic protein are restricted to the bradyzoite stage, with the LDH1-to-LDH2 isoenzyme switch occurring early during tachyzoite-to-bradyzoite conversion (PMID:9016946, PMID:12350375). As an enzyme, recombinant LDH2 displays broad substrate specificity, preferring 3-phenylpyruvate over pyruvate, efficiently using the NAD analog APAD, and — unlike LDH1 — lacking substrate inhibition; it is competitively inhibited by gossypol derivatives, dihydroxynaphthoic acids, and N-substituted oxamic acids (PMID:11704270). Functionally, LDH2 contributes to lactate fermentation that supplements energy production under physiological low-oxygen conditions, and its loss impairs chronic-stage cyst formation in vivo (PMID:29028143). Stage-specific expression is controlled at multiple levels: the LDH2 promoter is transcriptionally upregulated under bradyzoite-inducing alkaline conditions (PMID:9016946), its transcript abundance depends on the ATP-dependent chromatin-remodeling subunit TgRSC8 (PMID:21655329), and intron retention generates unspliced LDH2 transcripts during the stage transition (PMID:25777509).

1. 1997 High

   Establishing that T. gondii encodes a second LDH isoform answered whether the parasite deploys distinct metabolic enzymes across its life cycle, revealing LDH2 as a bradyzoite-restricted, transcriptionally stage-regulated gene.

   Evidence Northern blot/RT-PCR, isoelectric focusing/immunoblot isoform analysis, and CAT reporter assay with the LDH2 promoter under alkaline pH

   PMID:9016946

   Open questions at the time

   • Does not identify the transcription factors binding the promoter
   • Does not establish the enzyme's catalytic properties
2. 2001 High

   Kinetic characterization of purified recombinant LDH2 answered how its enzymology differs from LDH1 and from Plasmodium LDH, defining its substrate preference and inhibitor sensitivity.

   Evidence In vitro enzyme kinetics with recombinant proteins, substrate/inhibitor dose-response assays, and tachyzoite growth inhibition in fibroblasts

   PMID:11704270

   Open questions at the time

   • Physiological relevance of 3-phenylpyruvate preference in vivo unclear
   • Does not link enzymatic activity to a cellular phenotype
3. 2002 High

   Direct subcellular and stage-resolved localization answered where and when LDH2 is expressed, showing it is cytoplasmic and appears at the onset of bradyzoite conversion.

   Evidence Immunocytochemistry and immunoelectron microscopy in mouse lung/brain and cat intestine with stage-specific antibodies

   PMID:12350375

   Open questions at the time

   • Does not address the functional consequence of the isoenzyme switch
   • Timing of switch not tied to specific molecular triggers
4. 2004 Medium

   Knockdown of LDH addressed whether the enzyme is required for the developmental program, showing LDH expression is needed for differentiation and chronic infection.

   Evidence Stable antisense/RNAi knockdown lines, in vitro differentiation assays, and murine brain cyst burden measurement

   PMID:15459194

   Open questions at the time

   • Knockdown cannot separate LDH2-specific from LDH1 contributions
   • Residual expression may obscure full loss-of-function phenotype
5. 2009 Medium

   Over-expression addressed whether LDH2 actively promotes differentiation, showing excess LDH2 enhances cyst formation under alkaline conditions, implying a role beyond baseline glycolysis.

   Evidence Clonal over-expression lines, in vitro cyst formation assay under alkaline pH, and growth/virulence assays

   PMID:19422070

   Open questions at the time

   • Single lab, single differentiation readout
   • Mechanism linking LDH2 abundance to differentiation not defined
6. 2011 Medium

   Identifying TgRSC8 as a controller of LDH2 transcript levels answered how chromatin remodeling contributes to LDH2 regulation, adding an epigenetic layer to its stage-specific control.

   Evidence Insertional mutagenesis, qPCR for LDH2 transcript, and complementation rescue of TgRSC8

   PMID:21655329

   Open questions at the time

   • Does not show direct RSC8 occupancy at the LDH2 locus
   • Effect may be indirect within the broader chromatin program
7. 2015 Medium

   Detection of intron-retained LDH2 transcripts answered how isoform exchange is achieved rapidly, introducing post-transcriptional intron retention as a regulatory mechanism during stage transition.

   Evidence RT-PCR detection of unspliced transcript isoforms and characterization of regulatory elements in LDH transcription units

   PMID:25777509

   Open questions at the time

   • Functional consequence of retained introns on protein output not quantified
   • Splicing factors mediating retention unidentified
8. 2017 High

   Clean CRISPR and homologous-recombination knockouts resolved the specific role of LDH2 versus LDH1, showing LDH2 loss impairs chronic cyst burden and lactate fermentation supports energy production under low oxygen, with double deletion producing more severe defects.

   Evidence CRISPR/Cas9 and homologous-recombination knockouts (single and double), in vitro growth under 3% O2, murine cyst burden, and oligomycin A sensitivity assays

   PMID:29028143 PMID:28323833

   Open questions at the time

   • Precise metabolic flux through LDH2 not directly measured
   • How lactate fermentation integrates with mitochondrial metabolism unresolved

• The molecular link between LDH2's enzymatic activity and its requirement for cyst formation — whether lactate metabolism per se or a moonlighting differentiation function drives the phenotype — remains unresolved.
• No catalytically dead LDH2 rescue experiment reported
• Metabolic dependency of chronic-stage bradyzoites on LDH2 flux not directly quantified